Kerstin Putzker

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Novel High-Throughput Screen Identified S100A4 Inhibitors for Anti-Metastatic Therapy.

Novel High-Throughput Screen Identified S100A4 Inhibitors for Anti-Metastatic Therapy.

Journal: International journal of biological sciences

Published: March 15, 2025

IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening.

IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening.

Journal: Blood

Published: October 10, 2024

Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response.

Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response.

Journal: Molecular systems biology

Published: April 02, 2024

A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compounds.

A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compounds.

Journal: HemaSphere

Published: November 22, 2023

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2.

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2.

Journal: Frontiers in immunology

Published: August 03, 2023

Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis.

Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 25, 2023

Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics.

Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics.

Journal: Molecular systems biology

Published: December 23, 2022

Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling.

Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling.

Journal: PLoS computational biology

Published: April 18, 2022

Real-world evidence for preventive effects of statins on cancer incidence: A trans-Atlantic analysis.

Real-world evidence for preventive effects of statins on cancer incidence: A trans-Atlantic analysis.

Journal: Clinical and translational medicine

Published: December 02, 2021

Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer.

Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer.

Journal: Cell reports

Published: September 23, 2020

Drug-perturbation-based stratification of blood cancer.

Drug-perturbation-based stratification of blood cancer.

Journal: The Journal of clinical investigation

Published: March 08, 2017

Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity.

Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity.

Journal: Journal of medicinal chemistry

Published: January 31, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026